April 3, 2020: The Week in Cancer News
CAR-T cell therapy may help patients after a relapse of mantle cell lymphoma, and more news of the week...
Progress Against Cancer
CAR-T cell therapy may help patients after a relapse of mantle cell lymphoma, and more news of the week...
Cancer of the esophagus, a relatively rare cancer, is a diagnosis that approximately 18,440 Americans are expected to receive...
While COVID-19 is at the center of medical news, important cancer research findings continue to be reported. As March...
Guest post by Jeremy Warner, MD, MS, and Deborah Doroshow, MD, PhD The world is facing a pandemic unlike...
Cancer centers are making changes to care for some patients enrolled in trials.
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S....
A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
Barrett’s esophagus is a known risk factor for esophageal cancer.
The American Society for Radiation Oncology created guidelines to address controversies over when radiation should be used.
Typically, patients are treated with heparin, an injectable blood thinner, after a blood clot develops, but updated guidelines support...